IPO Performance of Medistep Healthcare and Studio LSD – August 2025
Medistep Healthcare IPO Highlights
Medistep Healthcare based in Ahmedabad launched its IPO from August 8 to 12, 2025, with a fixed price issue of ₹16.10 crore at ₹43 per share. The IPO saw overwhelming response with an oversubscription of approximately 382 times by the final day. Retail investors dominated with 461 times subscription.
The grey market premium (GMP) ranged between ₹10 to ₹13, indicating an estimated listing gain of 23% to 30%. Financially, Medistep reported revenue of ₹49.66 crore and net profit of ₹4.14 crore for FY25. The company focuses on health and hygiene related products. The issue was listed on NSE SME on August 18, 2025.
Studio LSD IPO Highlights
Studio LSD, a multimedia production company, launched a book building IPO from August 18 to 20, 2025, with issue size of ₹74.25 crore and price band ₹51-₹54. The IPO subscription was still open at the time of reporting with strong market anticipation.
For FY25, Studio LSD reported revenue of ₹104.48 crore and net profit of ₹11.67 crore. The return on net worth (RoNW) was 53.78% and return on capital employed (RoCE) was 57.29%, showing strong financial health. The IPO is expected to be listed on NSE SME on August 25, 2025.
Comparison Table
| IPO Name | Issue Dates | Issue Size (₹ Cr) | Price Per Share (₹) | Subscription (Times) | Listing Date | FY25 Revenue (₹ Cr) | PAT (₹ Cr) | RoNW (%) | ROCE (%) | GMP (₹) |
|---|---|---|---|---|---|---|---|---|---|---|
| Medistep Healthcare | 8–12 Aug 2025 | 16.10 | 43 | ~382x | 18 Aug 2025 | 49.66 | 4.14 | 29.06 | 38.91 | 10–13 |
| Studio LSD | 18–20 Aug 2025 | 74.25 | 51–54 | Open / Tentative | 25 Aug 2025 | 104.48 | 11.67 | 53.78 | 57.29 | 0 |
Summary
Medistep Healthcare’s IPO witnessed massive retail interest with significant oversubscription and a healthy grey market premium, indicating strong initial market sentiment. Studio LSD’s IPO, while larger and more financially robust, was still in the subscription phase with expectations of a strong listing backed by solid financial metrics.
Both IPOs represent promising investment opportunities in the SME sector, catering to different investor profiles and risk appetites.
Note: Please consult financial advisors before making investment decisions.
“`